A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-oct ahydrobenzo[d]isoxazol-4-one

Details for Australian Patent Application No. 2007315832 (hide)

Owner Abiogen Pharma S.p.A.

Inventors Neggiani, Fabio; Dini, Laura

Agent Fisher Adams Kelly

Pub. Number AU-A-2007315832

PCT Pub. Number WO2008/053325

Priority MI2006A002102 02.11.06 IT

Filing date 31 October 2007

Wipo publication date 8 May 2008

International Classifications

C07D 261/20 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

25 June 2009 PCT application entered the National Phase

  PCT publication WO2008/053325 Priority application(s): WO2008/053325

6 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007315833-A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-oct ahydrobenzo[d]isoxazol-4-one

2007315811-System and method for dissipating static electricity in an electronic sheet material dispenser